Socioeconomic impact of restless legs syndrome and inadequate restless legs syndrome management across European settings
Συγγραφέας
Trenkwalder C., Tinelli M., Sakkas G.K., Dauvilliers Y., Ferri R., Rijsman R., Oertel W., Jaarsma J.Ημερομηνία
2021Γλώσσα
en
Λέξη-κλειδί
Επιτομή
Restless legs syndrome (RLS) is one of the most common neurological disorders. It describes an irresistible urge to move the legs, mostly manifested in the evening and at night, which can lead to severe sleep disturbance. As part of the European Brain Council (EBC)-led Value-of-Treatment project, this study aimed at capturing the socioeconomic impact of RLS related to the inadequate diagnosis and treatment across different European healthcare settings. The economic burden of RLS was estimated using the published EBC framework of analysis in three separate European Union healthcare systems (France, Germany, and Italy). The RLS care pathway was mapped to identify the unmet needs of patients. Based on specific patient stories, the economic impact of correctly diagnosing RLS and changing between inadequate and target treatment was calculated using appropriate scenario analysis. RLS proved to be a significant personal and social burden, when epidemiological data, high prevalence of RLS, and its need for treatment are combined. By looking at the savings emerging from the provision of optimal care management (timely and correct diagnosis, evidence-based therapy, avoidance of therapy-related complications such as augmentation), the authors foresee substantial economic savings with the achievement of adequate diagnosis and treatment of RLS. Education about RLS is urgently needed for all subspecialties involved in RLS patient care as well as the general public. Equally important, the search for new causal treatment strategies should be intensified to reduce suffering and substantial societal cost. © 2020 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology
Collections
Related items
Showing items related by title, author, creator and subject.
-
Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: A combined task force of the IRLSSG, EURLSSG, and the RLS-foundation
Garcia-Borreguero D., Silber M.H., Winkelman J.W., Högl B., Bainbridge J., Buchfuhrer M., Hadjigeorgiou G., Inoue Y., Manconi M., Oertel W., Ondo W., Winkelmann J., Allen R.P. (2016)A Task Force was established by the International Restless Legs Syndrome Study Group (IRLSSG) in conjunction with the European Restless Legs Syndrome Study Group (EURLSSG) and the RLS Foundation (RLS-F) to develop ... -
Restless legs syndrome in Multiple Sclerosis patients: a contributing factor for fatigue, impaired functional capacity, and diminished health-related quality of life
Giannaki C.D., Aristotelous P., Stefanakis M., Hadjigeorgiou G.M., Manconi M., Leonidou E., Sakkas G.K., Pantzaris M. (2018)Objectives Restless legs syndrome (RLS) symptoms are common in Multiple Sclerosis (MS) patients. The aim of the current study was to examine for the first time whether RLS could affect the functional capacity and various ... -
Restless legs syndrome/Willis–Ekbom disease prevalence in beta thalassemia patients
Dimitriadou E., Giannaki C.D., Tsekoura M., Stefanidis I., Hadjigeorgiou G.M., Lavdas E., Karatzaferi C., Sakkas G.K. (2018)Purpose: Both beta thalassemia and restless legs syndrome (RLS) patients share some common pathophysiological characteristics related to iron handling. In the present study, the aim was to explore the prevalence of RLS as ...